Site Therapeutics aims to map—down to the nucleotide—the genetic determinants driving immune cell function in human health and disease. Leveraging technology developed in the Marson Lab at UCSF/Gladstone, we will conduct high-throughput functional genomics in human cells to build a blueprint for fine-tuned control of immune cell function. This detailed map will lead to the development of new therapeutics across modalities for a range of immune-related conditions. We are backed by The Column Group, a leading life sciences venture capital firm.
Site Therapeutics reposted this
We're hiring! Site Therapeutics is using novel technologies in functional genomics and protein modeling to revolutionize drug discovery. Join the team as its inaugural Computational Biologist and be part of building this exciting new company. #hiring #computationalbiology #drugdiscovery
Site Therapeutics reposted this
I'm excited to be officially joining the Site Therapeutics team as SVP of Data Science. This is my ideal move from the deeply satisfying experience I had at Maze Therapeutics, which is now moving multiple assets into the clinic. Like Maze, Site strives to understand variant function in the context of human health and disease and related cellular phenotypes. We are focusing on variation that drives immune cell function by building a high-throughput genomics platform based on work done in the Marson Lab at UCSF/Gladstone. In addition to the application of innovative new lab technologies, we will be developing a novel computational platform to accelerate target discovery and validation, thereby increasing the probability of success in our drug discovery programs. I am thrilled to be joining colleagues old and new in this next adventure.
Site Therapeutics reposted this
The Column Group is excited to start recruiting for its newest company Site Therapeutics in partnership with Alex Marson. We are looking for candidates that have experience in functional genomics, immunology, and small molecule drug discovery. https://lnkd.in/gvEEUfNg